心房心肌细胞限制性Gasdermin D切割促进房性心律失常发生
研究探讨了Gasdermin D(GSDMD)切割产生的N端片段(NT-GSDMD)在心房心肌细胞(ACM)中的作用及其对房性心律失常发生的影响。通过人类心房组织和改良AAV9小鼠模型,发现AF患者ACM中GSDMD切割增强,ACM限制性过表达NT-GSDMD增加起搏诱导的AF易感性,机制涉及IL-1β分泌、巨噬细胞浸润、线粒体ROS生成及促心律失常钙释放事件,且MitoTEMPO或Gsdmd基因敲除可预防。结论表明NT-GSDMD通过ROS驱动的线粒体功能障碍发挥不依赖细胞焦亡的促心律失常作用,靶向线粒体或抑制GSDMD可预防AF。
要点
- AF患者心房心肌细胞中GSDMD切割增强,NT-GSDMD过表达增加小鼠AF易感性。
- NT-GSDMD通过促进IL-1β分泌和巨噬细胞浸润,并上调膜修复机制避免细胞焦亡。
- NT-GSDMD直接靶向线粒体增加ROS生成,触发促心律失常钙释放事件。
核心结论
- NT-GSDMD在心房心肌细胞中发挥不依赖细胞焦亡的促心律失常作用,机制涉及ROS驱动的线粒体功能障碍。
- 靶向线粒体ROS或抑制GSDMD可预防AF,GSDMD是AF预防的新治疗靶点。
研究设计与样本
- 研究使用人类心房组织评估蛋白水平和定位,并采用改良腺相关病毒9在小鼠中建立心房心肌细胞限制性NT-GSDMD过表达模型。
- 通过起搏诱导AF评估易感性,并利用MitoTEMPO和Gsdmd基因敲除进行干预。
主要发现
- AF患者心房心肌细胞中GSDMD切割增强。
- 小鼠心房心肌细胞限制性过表达NT-GSDMD增加起搏诱导的AF易感性。
- NT-GSDMD孔形成促进心房心肌细胞分泌IL-1β,促进巨噬细胞浸润,同时上调ESCRT介导的膜修复机制,防止心房心肌细胞焦亡。
- 上调的NT-GSDMD直接靶向线粒体,增加线粒体ROS生成,触发促心律失常钙释放事件。
- 缺乏孔形成能力的突变NT-GSDMD无法引起线粒体功能障碍或诱导房性心律失常;Gsdmd基因敲除预防小鼠模型自发AF发生。
关键数值与推荐
- NT-GSDMD诱导的心律失常发生可被线粒体特异性抗氧化剂MitoTEMPO减轻。
临床怎么用
- 线粒体靶向治疗(减少ROS产生)或抑制GSDMD可预防AF诱发性,提示GSDMD作为AF预防的新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Enhanced inflammatory signalling causally contributes to atrial fibrillation (AF) development. Gasdermin D (GSDMD) is an important downstream effector of several inflammasome pathways. However, the role of GSDMD, particularly the cleaved N-terminal (NT)-GSDMD, in non-immune cells remains elusive. This study aimed to elucidate the function of NT-GSDMD in atrial cardiomyocytes (ACMs) and determine its contribution to atrial arrhythmogenesis. METHODS: Human atrial appendages were used to assess the protein levels and localization. A modified adeno-associated virus 9 was employed to establish ACM-restricted overexpression of NT-GSDMD in mice. RESULTS: The cleavage of GSDMD was enhanced in ACMs of AF patients. Atrial cardiomyocyte-restricted overexpression of NT-GSDMD in mice increased susceptibility to pacing-induced AF. The NT-GSDMD pore formation facilitated interleukin-1β secretion from ACMs, promoting macrophage infiltration, while up-regulating 'endosomal sorting complexes required for transport'-mediated membrane-repair mechanisms, which prevented inflammatory cell death (pyroptosis) in ACMs. Up-regulated NT-GSDMD directly targeted mitochondria, increasing mitochondrial reactive oxygen species (ROS) generation, which triggered proarrhythmic calcium-release events. The NT-GSDMD-induced arrhythmogenesis was mitigated by the mitochondrial-specific antioxidant MitoTEMPO. A mutant NT-GSDMD lacking pore-formation capability failed to cause mitochondrial dysfunction or induce atrial arrhythmia. Genetic ablation of Gsdmd prevented spontaneous AF development in a mouse model. CONCLUSIONS: These findings establish a unique pyroptosis-independent role of NT-GSDMD in ACMs and arrhythmogenesis, which involves ROS-driven mitochondrial dysfunction. Mitochondrial-targeted therapy, either by reducing ROS production or inhibition of GSDMD, prevents AF inducibility, positioning GSDMD as a novel therapeutic target for AF prevention.
引用
- Yuan Y, Martsch P, Chen X, et al. Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis. Eur Heart J. 2025. PMID: 39927987. doi:10.1093/eurheartj/ehaf024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。